Clinical Trial Update: Processed Amniotic Fluid (pAF) for the Treatment of Chronic Wounds [Phase 1, Phase 2]

View source ↗

Summary

A University of Utah-sponsored Phase 1/2 trial evaluating processed amniotic fluid (pAF) for chronic wounds was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wounds

Drugs mentioned

• Processed Amniotic Fluid (pAF) (processed amniotic fluid)

Snippet

Sponsor: University of Utah | Conditions: Wounds and Injuries | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-06-07